Gastroenterology

Gastroenterology

Volume 105, Issue 6, December 1993, Pages 1846-1856
Gastroenterology

Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival

https://doi.org/10.1016/0016-5085(93)91084-UGet rights and content

Abstract

Background: Transforming growth factor βs (TGF-βs) constitute a family of bifunctional polypeptide growth factors that either inhibit or stimulate cell proliferation. Perturbations in TGF-β expression and function may lead to loss of negative constraints on cell growth. In this study, we examined TGF-β expression in human pancreatic cancer. Methods: The distribution of TGF-β isoforms in 60 human pancreatic cancers was examined using immunohistochemical, Northern blot, and in situ hybridization techniques. Results: Immunohistochemical analysis showed the presence of TGF-β1 (47% of tumors), TGF-β2 (42% of tumors), and TGF-β3 (40% of tumors) in the cancer cells. The presence of TGF-β2 was associated with advanced tumor stage (P < 0.05). Furthermore, there was a significant correlation between the absence of TGF-βs in the tumors and longer postoperative survival. Northern blot analysis indicated that, by comparison with the normal pancreas, pancreatic adenocarcinomas showed 11- (P < 0.001), 7- (P < 0.05), and 9-fold (P < 0.001) increases in the messenger RNA (mRNA) levels encoding TGF-β1, TGF-β2, and TGF-β3, respectively. By in situ hybridization, these mRNA moieties colocalized with their respective proteins in the cancer cells. Conclusions: These findings show that human pancreatic cancers show increased levels of TGF-β isoforms and enhanced TGF-β mRNA expression and suggest that the presence of TGF-βs in pancreatic cancer cells may contribute to disease progression.

References (58)

  • A Andren-Sandberg

    Treatment with an LHRH analogue in patients with advanced pancreatic cancer

    Acta Chir Scand

    (1990)
  • H Frieβ et al.

    Treatment of duct carcinoma of the pancreas with the LH-RH-analogue buserelin

    Pancreas

    (1992)
  • B Gudjonsson

    Cancer of the pancreas. 50 years of surgery

    Cancer

    (1987)
  • JE Oertel et al.

    Pancreas

  • M Korc et al.

    Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha

    J Clin Invest

    (1992)
  • JJ Smith et al.

    Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonistic autocrine cycle

  • Y Yamanaka et al.

    Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness

    Anticancer Res

    (1993)
  • RL Baldwin et al.

    Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1

    Growth Factors

    (1993)
  • Y Yamanaka et al.

    Synthesis and expression of transforming growth factor-beta 1, beta2, and beta3 in the endocrine and exocrine pancreas

    Diabetes

    (1993)
  • CD Logsdon et al.

    Transforming growth factor-β (TGF-β1) inhibits pancreatic acinar cell growth

    Am J Physiol

    (1992)
  • P Hermanek et al.

    TNM Klassifikation maligner Tumoren

    (1987)
  • RW Pelton et al.

    Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development

    J Cell Biol

    (1991)
  • SM Gorsch et al.

    Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer

    Cancer Res

    (1992)
  • JN Wicox et al.

    Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization

    J Clin Invest

    (1988)
  • M Korc et al.

    Pancreatic islet-acinar cell interaction: amylase messenger RNA levels are determined by insulin

    Science

    (1981)
  • R Derynck et al.

    Human transforming growth factor-β complementary sequence and expression in normal and transformed cells

    Nature (Lond)

    (1985)
  • BA Arrick et al.

    Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines by estradiol

    Cancer Res

    (1990)
  • A Balmain et al.

    Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells

    Nucleic Acids Res

    (1982)
  • S Siegel

    Nonparametric statistics for behavioral sciences

    (1956)
  • Cited by (523)

    • Epithelial to Mesenchymal Transition

      2022, Comprehensive Pharmacology
    • A Decade Later: Revisiting the TGFβ Family's Role in Diabetes

      2021, Trends in Endocrinology and Metabolism
    • Targeting all transforming growth factor-b isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer

      2020, Journal of Biological Chemistry
      Citation Excerpt :

      Thus, our approach to combine two receptors in a single Fc chimeric protein assures the same distributions of both receptors and increases the probability of trapping, leading to more effective therapy. TGF-β2 is overexpressed in various cancer types, including glioma (12) and pancreatic cancer (42), and its expression is also correlated with tumor progression. Several studies have reported attempts to target TGF-β2 in tumor tissues.

    • TGF-β signaling in health, disease, and therapeutics

      2024, Signal Transduction and Targeted Therapy
    View all citing articles on Scopus

    Supported by Public Health Service grants CA-40162 (to M.K.) and CA-49507 (to L.I.G.), which were awarded by the National Cancer Institute.

    View full text